OTC Markets Group Appoints JP Chan to Lead Asia-Pacific Growth in Hong Kong
NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group (OTCQX: OTCM), operator of regulated ma…
globenewswire.com
SYNH(SYNH)
SYNH
+0.02%(+0.01)
Open
42.98
Prev Close
42.97
Day High
42.99
Day Low
42.97
Volume
6.7M
Avg Volume
1.3M
52W High
52.23
52W Low
22.89
Signal
Leaning Bullish1↑1!
PRICE
Prev Close
42.97
Open
42.98
Day Range42.97 – 42.99
42.97
42.99
52W Range22.89 – 52.23
22.89
52.23
68% of range
VOLUME & SIZE
Avg Volume
1.3M
FUNDAMENTALS
P/E Ratio
61.4x
Premium valuation
EPS (TTM)
—
Div Yield
No dividend
Beta
1.06
Market-like
Quick Read
Trend—Insufficient MA data
Momentum
NEUTRAL
rev +0% · 23% gross marginValuation
EXPENSIVE
P/E 61x vs ~20x sectorHealth
MODERATE
CR 1.1 · FCF $3.24/shNeutral
Key MetricsTTM
Market Cap$4.46B
Revenue TTM$5.42B
Net Income TTM$71.22M
Free Cash Flow$161.92M
Gross Margin23.3%
Net Margin4.9%
Operating Margin7.5%
Return on Equity7.7%
Return on Assets3.3%
Debt / Equity0.83
Current Ratio1.13
EPS TTM$2.59
Alpha SignalsView Intelligence →
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Health Radar
1 strong2 watch3 concern
35/100Liquidity
1.13Watch
Leverage
0.83Strong
Coverage
5.0xWatch
ROE
7.7%Concern
ROIC
5.2%Concern
Cash
$112MConcern
ANALYST COVERAGE23 analysts
HOLD
▲ +80.3%upside to target
L $25.00
Med $77.50consensus
H $105.00Stock Health
Composite Score
1 of 4 signals bullish
6/10
Technicals
●
~RSI RangeRSI 100 — Overbought, caution
Fundamentals
●
✓Last EarningsBeat estimates
●
~Analyst ConsensusHold
●
~LiquidityCurrent Ratio 1.13
1 signal unavailable — limited data for this stock
Upcoming Events
EEarnings ReportMay 4, 2026
Tomorrow
DEx-Dividend DateJul 31, 2026
In 89 days
PDividend PaymentOct 9, 2026
In 159 days
FinancialsFull statements →
Technicals
Technical SetupBULLISH
Technicals →Trend
▲ UptrendGolden Cross · 50D leads 200D by 7.8%
+0.8% vs SMA 50 · +8.7% vs SMA 200
Momentum
RSI100.0Overbought — pullback risk
MACD+4.93Above zero — bullish momentum · expanding
Market Position
Price Levels
52W High
$52.23+21.5%
Current
$42.98
EMA 50
$42.55-1.0%
52W Low
$22.89-46.7%
EMA 200
$0.6404-98.5%
52-Week RangeMid-range
$22.8968th %ile$52.23
Earnings & Analysts
Earnings HistorySYNH
Last 8Q
-4.6%avg beat
Beat 6 of 8 quartersMissed 2↓ Estimates falling+3%
Q1'22
+5%
Q2'22
+4%
Q3'22
-7%
Q4'22
+4%
Q1'23
+12%
Q2'23
-99%
Q3'23
+40%
Q4'23
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →No recent activity
J.P. MorganReduce
Feb 13
DOWNGRADE
BarclaysUnderweight → Reduce
Jan 23
DOWNGRADE
BarclaysOverweight → Underweight
Jan 13
DOWNGRADE
Zacks Investment Re…Hold
Apr 26
UPGRADE
JefferiesHold
Apr 25
DOWNGRADE
Financials
INSTITUTIONAL OWNERSHIP
1
Ergoteles LLC
0▼2
Berry Street Capital Management LLP
0▼3
PICTET ASSET MANAGEMENT SA
640K▲4
Endurance Wealth Management, Inc.
70—5
Kula Investments, LLC
9K▲6
ETF MANAGERS GROUP, LLC
0▼7
Perpetual Investment Management Ltd
0▼8
ROTHSCHILD & CO ASSET MANAGEMENT US INC.
0▼News & Activity
SYNH News
20 articles · 4h ago
BW Investors Have Opportunity to Lead Babcock & Wilcox Enterprises, Inc. Securities Fraud Lawsuit
prnewswire.com
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: EAI Robotics Sales Momentum Continues Along with University Collaborations and Partnership Development
businesswire.com
GameStop Is Offering to Buy eBay for $56 Billion, CEO Ryan Cohen Says
wsj.com
United Airlines plane hits light pole on landing at Newark airport
reuters.com
AQST Deadline: AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit
prnewswire.com
PMET Produces High Recovery (89%) and High Grade Spodumene Concentrate (6.1% Li2O) from Innovative CV5 Sample and DMS Pilot Program
prnewswire.com
OPEC+ agrees on third oil output quota hike since Hormuz closure
nypost.com
U.S. stock futures rise, oil falls as Trump touts new plan to partially reopen Strait of Hormuz
marketwatch.com
Oil falls after Trump says US would help free ships stranded in Strait of Hormuz
reuters.com
BSX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - BSX
globenewswire.com
Berkshire Hathaway at Crossroads: No Buffett, Record Markets, Big Questions
seeitmarket.com
Apple's Stance on Vibe Coding Apps Leaves Startups Frustrated
pymnts.com
The SpaceX IPO Will Create a $75 Billion Spending Spree -- These 2 AI Stocks Will Win
fool.com
CWH DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Camping World Holdings, Inc. Investors to Secure Counsel Before Important May 11 Deadline in Securities Class Action – CWH
globenewswire.com
Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis on May 4, 2026
businesswire.com
Why Figma Stock Fell 16% in April
fool.com
GameStop Eyes eBay Acquisition to Become $100 Billion Company
pymnts.com
ADMA Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
globenewswire.com
Stock, Oil Futures Poised to Trade Ahead of Jobs Week
barrons.com
About
inc research/inventiv health has become syneos health, the only fully integrated end-to-end clinical and commercial solution organization. we are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
Industry
Research and Development in Biotechnology
CEO
Michael Bell